Here's what we chose for you from NEJM Group today: New England Journal of Medicine: Perspective: As difficult as 2020 was, it also brought some...
Dear Readers, This marks our final issue of Physician's First Watch. Over the past couple of weeks, hundreds of you have written to us to...
Blood pressure (BP)–lowering treatment is associated with lower risk for cardiovascular (CV) events across a wide range of BP levels and in patients with...
Higher body-mass index is associated with increased risk for severe COVID-19–related outcomes, even at a BMI considered a healthy weight, according to...
The FDA has embarked on a process to ban menthol cigarettes and all flavored cigars. In a statement released Thursday, the acting FDA commissioner, Dr...
Here's what we chose for you from NEJM Group today: NEJM Audio Interview: Firearm Regulation in Australia: Dr. Joel Negin discusses the anniversary of sweeping...
This is the fourth of four Clinical Conversations interviews on race and clinical equity in the U.S. We talk with Dr. Joseph Betancourt, an internist...
For patients with respiratory infections, delaying antibiotics could be a safe way to reduce antibiotic use, according to a study in The BMJ. Researchers analyzed...
Among hospitalized older adults with COVID-19–like illness, those who tested negative for COVID-19 were far more likely to have been vaccinated than...
See what's happening around NEJM Group: NEJM Primary Care/Hospitalist Page: Case record: A 78-year-old man was admitted with a forehead and scalp...
Polypharmacy, commonly defined as taking five or more medications daily, is a significant health care concern impacting over 30% of older adults.
A drug commonly used to treat glaucoma has been shown in zebrafish and mice to protect against the build-up in the brain of the protein tau, which causes various forms of dementia and is implicated in Alzheimer's disease.